Metropolitan Life Insurance Company (MetLife)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $208K | Sell |
|
|||||
|
2022
Q1 | $80.1K | Sell |
|
|||||
|
2021
Q4 | $574K | Hold |
|
|||||
|
2021
Q3 | $799K | Sell |
|
|||||
|
2021
Q2 | $985K | Buy |
|
|||||
|
2021
Q1 | $956K | Sell |
|
|||||
|
2020
Q4 | $1.28M | Buy |
|
|||||
|
2020
Q3 | $864K | Buy |
|
|||||
|
2020
Q2 | $560K | Sell |
|
|||||
|
2020
Q1 | $398K | Buy |
|
|||||
|
2019
Q4 | $540K | Buy |
|
|||||
|
2019
Q3 | $120K | Buy |
|
|||||
|
2019
Q2 | $28.2K | Buy |
|